Viridian Therapeutics
VRDN
VRDN
165 hedge funds and large institutions have $1.98B invested in Viridian Therapeutics in 2024 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 66 increasing their positions, 41 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
20% more funds holding
Funds holding: 138 → 165 (+27)
4.75% more ownership
Funds ownership: 109.13% → 113.88% (+4.8%)
8% more call options, than puts
Call options by funds: $13.9M | Put options by funds: $12.9M
Holders
165
Holding in Top 10
10
Calls
$13.9M
Puts
$12.9M
Top Buyers
| 1 | +$45.3M | |
| 2 | +$44.6M | |
| 3 | +$36.6M | |
| 4 |
FFM
Fairmount Funds Management
West Conshohocken,
Pennsylvania
|
+$36.4M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$27.4M |
Top Sellers
| 1 | -$29.8M | |
| 2 | -$11.7M | |
| 3 | -$11.6M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$8.93M |
| 5 |
RI
RTW Investments
New York
|
-$7.88M |